Package Leaflet: Information for the User
Glucose 3.33% and Sodium Chloride 0.3% Baxter Solution for Infusion
Active ingredient: sodium chloride, glucose
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is called Glucose 3.33% and Sodium Chloride 0.3% Baxter Solution for Infusion, but will be referred to as “Glucose 3.33% and Sodium Chloride 0.3% Baxter” throughout this leaflet.
Contents of the pack and other information
Contents of the pack and further information
Glucose 3.33% and Sodium Chloride 0.3% Baxter is a solution of the following substances in water:
Glucose is one of the body's sources of energy. This solution provides 132 kilocalories per liter. Sodium and chloride are chemical substances found in the blood.
Glucose 3.33% and Sodium Chloride 0.3% Baxter is used:
Warnings and precautions
Tell your doctor if you have or have had any of the following conditions:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you are being given this solution, your doctor will take blood and urine samples to monitor:
Since Glucose 3.33% and Sodium Chloride 0.3% Baxter contains sugar (glucose), it may increase blood sugar levels (hyperglycemia). If this happens, your doctor may:
This is especially important:
Your doctor should consider whether you are receiving parenteral nutrition (nutrition given by infusion into a vein). During prolonged treatment with Glucose 3.33% and Sodium Chloride 0.3% Baxter, you may need to receive extra nutrition. Your doctor should monitor your blood potassium levels to prevent them from falling too low (hypokalemia).
Children
Special care should be taken when giving this solution to children, babies, and newborns (especially premature babies and those with low birth weight). Children, babies, and newborns may not have a good ability to handle the chemicals in the solution.
Younger children are at higher risk of developing low or high blood sugar levels and therefore need careful monitoring during intravenous infusion treatment to ensure proper control of blood sugar levels. Low blood sugar levels in newborns can cause prolonged seizures, coma, and brain damage. High blood sugar levels have been associated with brain hemorrhages, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections, lung problems, prolonged hospital stay, and death.
Children are at higher risk of developing low sodium levels in the blood (hyponatremia). Hyponatremia can cause headache, nausea, seizures, lethargy, coma, brain inflammation (cerebral edema), and death. Acute hyponatremic encephalopathy is a serious complication, especially in children.
Your doctor is aware of all of the above and will carefully monitor the levels of chemicals such as glucose (sugar), sodium, and chloride in your child's blood (plasma electrolytes).
Other medicines and Glucose 3.33% and Sodium Chloride 0.3% Baxter
Tell your doctor or nurse if you are using or have recently used any other medicines.
It is especially important that you tell your doctor if you are taking:
These medicines can cause the body to retain sodium and water, leading to tissue swelling due to fluid accumulation under the skin (edema) or high blood pressure (hypertension).
Some medicines affect the hormone vasopressin. These may include:
Other medicines that may be affected by or affect Glucose 3.33% and Sodium Chloride 0.3% Baxter are:
Using Glucose 3.33% and Sodium Chloride 0.3% Baxter with food and drink
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medicine.
Glucose 3.33% and Sodium Chloride 0.3% Baxter can be used safely during pregnancy and breastfeeding.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Glucose 3.33% and Sodium Chloride 0.3% Baxter does not affect your ability to drive or use machines.
Glucose 3.33% and Sodium Chloride 0.3% Baxter will be given to you by a doctor or nurse. Your doctor will decide how much you need and when it should be given. This will depend on your age, weight, medical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
You should not receive Glucose 3.33% and Sodium Chloride 0.3% Baxter if there are particles floating in the solution or if the container is damaged in any way.
Glucose 3.33% and Sodium Chloride 0.3% Baxter is usually given through a plastic tube attached to a needle inserted into a vein. A vein in the arm is usually used to give the infusion. However, your doctor may give you the medicine in another way.
Before and during the infusion, your doctor will monitor:
Any unused solution should be discarded. You should not receive Glucose 3.33% and Sodium Chloride 0.3% Baxter from a bottle that has already been used.
If you receive more Glucose 3.33% and Sodium Chloride 0.3% Baxter than you should
If you receive too much Glucose 3.33% and Sodium Chloride 0.3% Baxter or if it is given too quickly, you may experience the following symptoms:
If you develop these symptoms, tell your doctor immediately. The infusion will be stopped and you will receive treatment based on your symptoms.
If a medicine has been added to Glucose 3.33% and Sodium Chloride 0.3% Baxter before an overdose occurs, you should be aware that the added medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you stop receiving Glucose 3.33% and Sodium Chloride 0.3% Baxter
Your doctor will decide when you should stop receiving this infusion.
If you have any further questions about the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects may be due to the infusion technique. These include:
If a medicine has been added to the infusion solution, it may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
Reporting side effects:
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. If any of these occur, the infusion should be stopped. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Glucose 3.33% and Sodium Chloride 0.3% Baxter should not be administered after the expiry date stated on the bottle after EXP. The expiry date is the last day of the month shown.
You should not receive Glucose 3.33% and Sodium Chloride 0.3% Baxter if there are particles floating in the solution or if the container is damaged in any way.
The active ingredients are:
The other component is water for injectable preparations.
Appearance of the product and packaging content
Glucose 3.33% and Sodium Chloride 0.3% Baxter is a clear, particle-free solution. It is presented in Type II glass vials.
The vial sizes are 50 ml, 100 ml, 250, 500, or 1,000 ml.
The vials are packaged in cardboard boxes. Each cardboard box contains one of the following quantities:
25 vials of 50 ml
25 vials of 100 ml
30 vials of 250 ml
10 vials of 500 ml
10 vials of 1000 ml
Only some packaging sizes may be marketed.
Marketing authorization holder and manufacturer
Holder
Baxter S.L.
Polígono Industrial Sector 14. Pouet de Camilo 2,
46394 Ribarroja del Turia (Valencia)
Spain
Manufacturer:
Bieffe Medital S.p.A. Via Nuova Provinciale, 23304 Grosotto (So), Italy |
Date of the last revision of this prospectus:June 2019
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for healthcare professionals
Handling and preparation
Use only if the solution is clear, free of visible particles, and the container is not damaged. Administer immediately after connecting the infusion equipment.
The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution to prevent air from entering the system.
Medications can be introduced before or during infusion through the injection point. When adding medications, check the isotonicity before parenteral administration.
From a physical-chemical point of view, the solution containing added medications should be used immediately unless the chemical and physical stability in use has been established.
From a microbiological point of view, solutions containing added medications should be used immediately. If not used immediately, the storage times and conditions prior to use are the responsibility of the user and should not normally exceed 24 hours between 2 and 8°C, unless the addition has taken place in controlled and validated aseptic conditions.
Discard after a single use.
Discard partially used vials.
Do not reconnect partially used vials.
1- To open
2- Preparation for administration
Use sterile material for preparation and administration.
3- Techniques for injecting added medication
Warning: added medications may be incompatible (see section 5 "Incompatibilities of added medications").
To add medications before administration:
Precaution: Do not store vials with added medication; see paragraph 4 "Expiry in use (added medications)".
To add medications during administration:
Before use, the physical and chemical stability of any added medication at the pH of the Glucose 3.33% and Sodium Chloride 0.3% Baxter solution must be established.
From a physical-chemical point of view, the solution containing added medications should be used immediately unless the chemical and physical stability in use has been established.
From a microbiological point of view, the diluted product should be used immediately. If not used immediately, the storage time and conditions prior to use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless the addition of medications has taken place in controlled and validated aseptic conditions.
5- Incompatibilities of added medications
As with all parenteral solutions, the compatibility of added medications with the solution must be verified before addition.
It is the responsibility of the physician to judge the incompatibility of the added medication with Glucose 3.33% and Sodium Chloride 0.3% Baxter by examining any change in color and/or precipitation, insoluble complexes, or crystal formation. The medication's prospectus should be consulted.
Before adding a medication, verify that it is soluble and stable in water at the pH of Glucose 3.33% and Sodium Chloride 0.3% Baxter (pH 3.5 – 6.5).
When adding compatible medication to Glucose 3.33% and Sodium Chloride 0.3% Baxter, the solution should be administered immediately unless the chemical and physical stability in use has been established.
As a guide, the following medications are incompatible with Glucose 3.33% and Sodium Chloride 0.3% Baxter (this is not an exhaustive list):
Since Glucose 3.33% and Sodium Chloride 0.3% Baxter contains glucose, it should not be administered with whole blood through the same infusion equipment due to the possibility of hemolysis and agglutination.
Medications that are known to be incompatible should not be used.